HenryBremMD

PubMed

• 129 citations
  Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
  Louis B. Nabors, Jana Portnow, Manmeet Ahluwalia, Joachim Baehring, Henry Brem
  Journal of the National Comprehensive Cancer Network. 2020-11-02
• 224 citations
  TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
  Alice L. Hung, Russell Maxwell, Debebe Theodros, Zineb Belcaid, Dimitrios Mathios
  Oncoimmunology. 2018-05-24
• 31 citations
  Risk Factors for Preoperative Seizures and Loss of Seizure Control in Patients Undergoing Surgery for Metastatic Brain Tumors
  Adela Wu, Jon D. Weingart, Gary L. Gallia, Michael Lim, Henry Brem
  World Neurosurgery. 2017-08-01

Journal Articles

• Ny-Eso-1 Is Frequently Expressed In Meningioma And Is A Target For Immunotherapeutic Approaches  
  Baia GS, Caballero OL, Ho SJ, Zhao Q, Cohen T, Goldthwaite P, Gallia GL, Quinones-Hinojosa A, Brem H, Burger P, Simpson AJ, Eberhart C, Riggins GJ, Cancer Immunology Research, 11/1/2013
• Identifying better surgical candidates among RPA class 2 patients who underwent surgery for intracranial metastes  
  Chaikhana KL, Acharya S, Flores M, Wijesekera O, Rigamonti D, Weingart JD, Olivi A, Bettegowda C, Gallia GL, Brem H, Quinones-Hinojosa A, World Neurosurg., 9/24/2013
• Factors associated with survival and recurrence for patients undergoing surgery of cerebellar metastases  
  Chaichana KL, Rao K, Gadkaree S, Dangelmajer S, Bettegowsda C, Rigamonti D, Weingart J, Olivi A, Gallia GL, Brem H, Lim M, Quinones-Hinojosa A, Neurol Res, 9/9/2013
• Patients undergoing surgery of intracranial metastases have different outcomes based on their primary pathology  
  Chaichana KL, Gadkaree S, Rao K, Link T, Rigamonti D, Purtell M, Browner I, Weingart J, Olivi A, Gallia GL, Bettegowda C, Brem H, Lim M, Quinones-Hinojosa A, Neurol Res, 8/16/2013
• Survival and Recurrence for Patients Undergoing Surgery of Skull Base Intracranial Metastases  
  Chaichana KL, Flores M, Acharya S, Sampognaro P, Bettegowda C, Rigamonti D, Weingart JD, Olivi A, Gallia GL, Brem H, Lim M, Quinones-Hinojosa A, J Neurol Surg B, 1/1/2013
• Multiple resections for patients with glioblastoma: prolonging survival  
  Chaichana KL, Zadnik P, Weingart JD, Olivi A, Gallia GL, Blakeley J, Lim M, Brem H, Quiñones-Hinojosa A, J Neurosurg., 1/1/2013
• Longitudinal IN VIVO Monitoring of rodent GLIOMA MODELS through thinned skull using Laser Speckle Contrast Imaging  
  Rege A, Seifert AC, Schlattman D, Ouyang Y, Li KW, Basaldella L, Brem H, Tyler BM, Thakor NV, J Biomed Opt., 1/1/2012
• Growth properties of SF 188/V+ human glioma in rats observed by magnetic resonance imaging  
  Grossman R, Tyler B, Brem H, Eberhart CG, Wand S, Fu DX, Wen Z, Zhou J, J Neurooncol., 1/1/2012
• Supression of Human Glioma Xenografts with 2nd Generation IL13R-Specific Chimeric Antigen receptor-Modified T Cells  
  Kong S, Senqupta S, Tyler BM, Ma Q, Doucette S, Zhou J, Sahin A, Carter B, Brem H, Junghans RP, Sampath P, Clin Cancer Res., 1/1/2012
• Central Nervous System Cancers  
  Brem SS, Bierman PJ, Brem H, Butowski N, Chamberlain MC, Chiocca EA, Deangelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hesser D, Junck L, Linette GP, Loeffler JS,..., J Natl Compr Canc Netw., 1/1/2011
• Epirubicin exhibits potent anti-tumor activity in an animal model of malignant glioma when administered via controlled-release polymers  
  Recinos VR, Bekelis K, Ziegler SG, Vick D, Hertig S, Tyler BM, Li KW, Kosztowski T, Legnani FG, Brem H, Olivi A, J.Neurooncol., 1/1/2010
• Central nervous system cancers  
  Brem SS, Bierman PJ, Black P, Brem H, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Glass J, Grossman SA, Heimberger AB, Junck L, ..., J.Natl.Compr.Canc Netw., 1/1/2008
• Novel delivery systems in cancer chemotherapy  
  Moses MA, Brem H, Langer R, Sci & Med, 7/1/2004
• Diffusion tensor imaging and fiber tracking of brain tumors  
  Mori S, Kraut MA, Van Zul PC, Solaiyappa M, Brem H, Pomer M, Proceedings of the International Society of Magnetic Resonance in Medicine, 1/1/2001
• Primary tumors of the choroids plexus  
  Haroun RI, Lee KW, Carson BS, Brem H, Contemporary Neurosurgery, 1/1/2000
• Hemorrhagic vestibular schwannoma: an unusual clinical entity Case report  
  Chou D, Sampath P, Brem H, Neurosurg.Focus, 1/1/1998
• Treatment of brain tumors by local delivery of chemotherapy via biodegradable polymers  
  Bohan E, Brem H, Hospital Pharmacist Report, 1/1/1997
• Morphological characterization of polyanhydride biodegradable implant GliadelR during in vitro and in vivo erosion using scanning electron microscopy  
  Dang W, Daviau T, Brem H, Pharmaceutical Research, 1/1/1996
•  
  Utsuki T, Brem H, Pitha J, Loftsson T, Kristmundsdottir T, Tyler BM, Olivi A, Journal of Controlled Release, 1/1/1996
• Local delivery of BCNU from biodegradable polymer is superior to radiation therapy in treating intracranial melanoma metastases  
  Ewend MG, Anderson R, Tabassi K, Tyler BM, Babel KM, Williams JA, Brem H, Surgical Forum, 1/1/1996
• Potential in the treatment of brain tumours  
  Weingart JD and Brem H, CNS Drugs, 1/1/1996
• Polymer-based drug delivery to the brain  
  Brem H and Langer R, Scientific American: Science & Medicine, 1/1/1996
• Intratumoral chemotherapy  
  Walter KA, Tamargo RJ, Olivi A, Burger PC, Brem H, Neurosurgery, 1/1/1995
• Ocular and brain biocompatibility of polymeric delivery materials prepared from ester derivatives of hyaluronic acid  
  Olivi A, Kim KD, Benedetti L, Epstein JI, Pinn, ML, Callegaro L, and Brem H, J of Clinical Materials, 1/1/1993
• Polymers as controlled drug delivery devices for the treatment of malignant brain tumors  
  Brem H, Walter, KA, Langer R, Eur. J. Pharm. & Biopharm, 1/1/1993
• Join now to see all

Lectures

• International Updates in Neuro-Oncology 
  The Johns Hopkins University School of Medicine, Baltimore, Maryland - 9/20/2012